We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Will Acute Care Unit Aid Universal Health's (UHS) Q1 Earnings?
Read MoreHide Full Article
Universal Health Services, Inc. (UHS - Free Report) is slated to release first-quarter 2024 results on Apr 24, after market close.
Q1 Estimates
The Zacks Consensus Estimate for UHS’ first-quarter earnings per share is pegged at $3.14, which indicates an improvement of 34.2% from the year-ago quarter’s reported figure.
The consensus mark for revenues is $3.8 billion, suggesting 8.7% growth from the year-ago quarter’s tally.
Earnings Surprise History
Universal Health boasts an impressive earnings surprise history. Its bottom line beat estimates in each of the trailing four quarters, the average surprise being 5.87%. This is depicted in the chart below:
Universal Health Services, Inc. Price and EPS Surprise
Our proven model predicts an earnings beat for Universal Health this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat, which is the case here.
Earnings ESP: Universal Health has an Earnings ESP of +8.56% because the Most Accurate Estimate of $3.41 is pegged higher than the Zacks Consensus Estimate of $3.14. You can uncover the best stocks before they’re reported with our Earnings ESP Filter.
Zacks Rank: UHS carries a current Zacks Rank of 2.
Factors to Note
Universal Health’s revenues are expected to have benefited on the back of growing contributions from the Acute Care Hospital Services and Behavioral Health Care Services segments in the first quarter. Strong patient volumes are likely to have provided an impetus to the units’ quarterly performance.
Results of the Acute Care Hospital Services unit are likely to have gained from improved adjusted admissions and growth in surgical volumes. However, the escalation in physician expenses is likely to have hurt the performance of the unit.
The Zacks Consensus Estimate for net revenues in the Acute Care Hospital Services segment is pegged at $2.1 billion, which indicates an improvement of 8.7% from the year-ago quarter. We expect it to improve 8% year over year in the to-be-reported quarter. Our estimate for same-facility adjusted admissions in the unit suggests 5.9% growth from the year-ago quarter’s reported figure.
In the first quarter, the Behavioral Health Care Services segment is expected to have been aided by the sustained demand for its behavioral services and improved same-store adjusted patient days.
The Zacks Consensus Estimate for net revenues in the Behavioral Health Care Services segment is pegged at $1.6 billion, which implies a 7.7% rise from the year-ago quarter’s reported number. We estimate it to grow 6.9% year over year in the to-be-reported quarter. We anticipate the unit's adjusted patient days to increase 2.4% year over year.
However, the margins of Universal Health are likely to have suffered a blow due to elevated salaries, wages and benefits coupled with a rise in supplies expense in the first quarter. We expect overall salaries, wages and benefits, and supplies expense to escalate 6.2% and 5.3%, respectively, on a year-over-year basis.
Other Stocks to Consider
Here are some companies from the Medical space, which according to our model, also have the right combination of elements to beat on earnings this time around:
The Zacks Consensus Estimate for HCA’s first-quarter 2024 earnings is pegged at $5.01 per share, indicating a rise of 1.6% from the year-ago quarter’s reported number.
HCA Healthcare’s earnings beat estimates in three of the trailing four quarters and missed the mark once, the average surprise being 9.78%.
Insulet Corporation (PODD - Free Report) has an Earnings ESP of +11.11% and a Zacks Rank of 2, at present. The Zacks Consensus Estimate for PODD’s first-quarter 2024 earnings is pegged at 39 cents per share, which implies a 69.6% rise from the year-ago quarter’s reported figure.
Insulet’s earnings beat estimates in each of the trailing four quarters, the average surprise being 100.09%.
Edwards Lifesciences Corporation (EW - Free Report) has an Earnings ESP of +1.02% and a Zacks Rank of 3, at present. The Zacks Consensus Estimate for EW’s first-quarter 2024 earnings is pegged at 64 cents per share, which indicates an improvement of 3.2% from the year-ago quarter’s reported figure.
Edwards Lifesciences’ earnings beat estimates in two of the trailing four quarters and matched the mark twice, the average surprise being 0.80%.
Image: Shutterstock
Will Acute Care Unit Aid Universal Health's (UHS) Q1 Earnings?
Universal Health Services, Inc. (UHS - Free Report) is slated to release first-quarter 2024 results on Apr 24, after market close.
Q1 Estimates
The Zacks Consensus Estimate for UHS’ first-quarter earnings per share is pegged at $3.14, which indicates an improvement of 34.2% from the year-ago quarter’s reported figure.
The consensus mark for revenues is $3.8 billion, suggesting 8.7% growth from the year-ago quarter’s tally.
Earnings Surprise History
Universal Health boasts an impressive earnings surprise history. Its bottom line beat estimates in each of the trailing four quarters, the average surprise being 5.87%. This is depicted in the chart below:
Universal Health Services, Inc. Price and EPS Surprise
Universal Health Services, Inc. price-eps-surprise | Universal Health Services, Inc. Quote
What our Quantitative Model Unveils
Our proven model predicts an earnings beat for Universal Health this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat, which is the case here.
Earnings ESP: Universal Health has an Earnings ESP of +8.56% because the Most Accurate Estimate of $3.41 is pegged higher than the Zacks Consensus Estimate of $3.14. You can uncover the best stocks before they’re reported with our Earnings ESP Filter.
Zacks Rank: UHS carries a current Zacks Rank of 2.
Factors to Note
Universal Health’s revenues are expected to have benefited on the back of growing contributions from the Acute Care Hospital Services and Behavioral Health Care Services segments in the first quarter. Strong patient volumes are likely to have provided an impetus to the units’ quarterly performance.
Results of the Acute Care Hospital Services unit are likely to have gained from improved adjusted admissions and growth in surgical volumes. However, the escalation in physician expenses is likely to have hurt the performance of the unit.
The Zacks Consensus Estimate for net revenues in the Acute Care Hospital Services segment is pegged at $2.1 billion, which indicates an improvement of 8.7% from the year-ago quarter. We expect it to improve 8% year over year in the to-be-reported quarter. Our estimate for same-facility adjusted admissions in the unit suggests 5.9% growth from the year-ago quarter’s reported figure.
In the first quarter, the Behavioral Health Care Services segment is expected to have been aided by the sustained demand for its behavioral services and improved same-store adjusted patient days.
The Zacks Consensus Estimate for net revenues in the Behavioral Health Care Services segment is pegged at $1.6 billion, which implies a 7.7% rise from the year-ago quarter’s reported number. We estimate it to grow 6.9% year over year in the to-be-reported quarter. We anticipate the unit's adjusted patient days to increase 2.4% year over year.
However, the margins of Universal Health are likely to have suffered a blow due to elevated salaries, wages and benefits coupled with a rise in supplies expense in the first quarter. We expect overall salaries, wages and benefits, and supplies expense to escalate 6.2% and 5.3%, respectively, on a year-over-year basis.
Other Stocks to Consider
Here are some companies from the Medical space, which according to our model, also have the right combination of elements to beat on earnings this time around:
HCA Healthcare, Inc. (HCA - Free Report) currently has an Earnings ESP of +13.46% and a Zacks Rank of 2. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for HCA’s first-quarter 2024 earnings is pegged at $5.01 per share, indicating a rise of 1.6% from the year-ago quarter’s reported number.
HCA Healthcare’s earnings beat estimates in three of the trailing four quarters and missed the mark once, the average surprise being 9.78%.
Insulet Corporation (PODD - Free Report) has an Earnings ESP of +11.11% and a Zacks Rank of 2, at present. The Zacks Consensus Estimate for PODD’s first-quarter 2024 earnings is pegged at 39 cents per share, which implies a 69.6% rise from the year-ago quarter’s reported figure.
Insulet’s earnings beat estimates in each of the trailing four quarters, the average surprise being 100.09%.
Edwards Lifesciences Corporation (EW - Free Report) has an Earnings ESP of +1.02% and a Zacks Rank of 3, at present. The Zacks Consensus Estimate for EW’s first-quarter 2024 earnings is pegged at 64 cents per share, which indicates an improvement of 3.2% from the year-ago quarter’s reported figure.
Edwards Lifesciences’ earnings beat estimates in two of the trailing four quarters and matched the mark twice, the average surprise being 0.80%.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.